Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $455.99 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $122.20 | 11 | $0 (2021) |
| Kedrion Biopharma, Inc. | $61.91 | 1 | $0 (2023) |
| Lilly USA, LLC | $57.44 | 4 | $0 (2021) |
| Novo Nordisk Inc | $50.26 | 4 | $0 (2022) |
| Amgen Inc. | $40.59 | 3 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $28.77 | 2 | $0 (2021) |
| CSL Behring | $15.80 | 1 | $0 (2023) |
| IBSA Pharma Inc. | $14.76 | 1 | $0 (2021) |
| Collegium Pharmaceutical, Inc. | $14.28 | 1 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.19 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $77.71 | 2 | Kedrion Biopharma, Inc. ($61.91) |
| 2022 | $12.06 | 1 | Novo Nordisk Inc ($12.06) |
| 2021 | $366.22 | 29 | AbbVie Inc. ($122.20) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/20/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 08/23/2023 | Kedrion Biopharma, Inc. | Albuked (Biological), KOATE, GAMMAKED | Food and Beverage | Cash or cash equivalent | $61.91 | General |
| Category: Critical Care | ||||||
| 02/08/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: Diabetes | ||||||
| 12/17/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.58 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $11.73 | General |
| Category: Neurology | ||||||
| 10/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Neuroscience | ||||||
| 09/23/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: DIABETES | ||||||
| 09/21/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Bone Health | ||||||
| 09/16/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.08 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: Diabetes | ||||||
| 08/24/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.28 | General |
| Category: Opioid Analgesic | ||||||
| 08/16/2021 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Central Nervous System | ||||||
| 08/12/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Diabetes | ||||||
| 07/13/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Obesity | ||||||
| 07/07/2021 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Central Nervous System | ||||||
| 06/15/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Bone Health | ||||||
| 06/03/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Diabetes | ||||||
| 04/28/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Diabetes | ||||||
| 04/16/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 210 | 218 | $72,644 | $10,403 |
| 2022 | 8 | 231 | 250 | $57,036 | $13,411 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 35 | $11,125 | $3,249 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 39 | $12,205 | $2,024 | 16.6% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 36 | 36 | $4,483 | $1,460 | 32.6% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 16 | 16 | $20,624 | $1,274 | 6.2% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 18 | 18 | $15,516 | $909.90 | 5.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 21 | $6,615 | $823.02 | 12.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 20 | 20 | $991.00 | $324.00 | 32.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 11 | 19 | $665.00 | $308.18 | 46.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 14 | $420.00 | $30.80 | 7.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 63 | $19,845 | $4,391 | 22.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 55 | 59 | $7,316 | $2,398 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 23 | $7,245 | $2,394 | 33.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 38 | 40 | $12,600 | $1,905 | 15.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $3,780 | $907.30 | 24.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 15 | 15 | $4,725 | $798.55 | 16.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 17 | 25 | $875.00 | $407.12 | 46.5% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 12 | 13 | $650.00 | $210.60 | 32.4% |
About David Kopsco, NP
David Kopsco, NP is a Family healthcare provider based in Columbus, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2019. The National Provider Identifier (NPI) number assigned to this provider is 1659916054.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Kopsco, NP has received a total of $455.99 in payments from pharmaceutical and medical device companies, with $77.71 received in 2023. These payments were reported across 32 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($455.99).
As a Medicare-enrolled provider, Kopsco has provided services to 441 Medicare beneficiaries, totaling 468 services with total Medicare billing of $23,814. Data is available for 2 years (2022–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Columbus, NJ
- Active Since 11/10/2019
- Last Updated 06/27/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1659916054
Products in Payments
- VRAYLAR (Drug) $122.20
- Albuked (Biological) $61.91
- TRULICITY (Drug) $57.44
- AJOVY (Biological) $28.77
- EVENITY (Biological) $27.62
- Ozempic (Drug) $27.17
- Kcentra (Biological) $15.80
- Tirosint (Drug) $14.76
- XTAMPZA (Drug) $14.28
- TRINTELLIX (Drug) $14.19
- Aimovig (Biological) $12.97
- JARDIANCE (Drug) $12.37
- Wegovy (Drug) $11.87
- Dayvigo (Drug) $11.73
- Strensiq (Drug) $11.69
- RYBELSUS (Drug) $11.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Columbus
Teresa Miller, Cnp, CNP
Family — Payments: $26,526
Beth Loessin
Family — Payments: $17,544
Eileen Faulds, Aprncnp, APRNCNP
Family — Payments: $13,709
Tarsicio Gacheru, Cnp, CNP
Family — Payments: $13,480
Toni Seibert, Apn, APN
Family — Payments: $13,241
Mary Hurley, Np-C, NP-C
Family — Payments: $11,853